3rd Quarter - Report
PARRY, ROMANI, DECONCINI & SYMMS for MEDICIS PHARMACEUTICAL CORPORATION
Income
$36,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Assist company in obtaining exception to FDA regulations concerning chlorofluorocarbons (CFCs) to maintain patient access to important medication.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Copyright/Patent/Trademark CPT
Oppose bills that prohibit brand name drug companies from settling patent litigation with generic drug companies and for other purposes. S. 27, Preserve Access to Affordable Generics Act and H.R. 3995, Protecting Consumer Access to Generic Drugs Act of 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.